Active Ingredient: AMPICILLIN SODIUM; SULBACTAM SODIUM
Proprietary Name: AMPICILLIN AND SULBACTAM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A065074
Product Number: 001
Approval Date: Mar 19, 2002
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: AMPICILLIN SODIUM; SULBACTAM SODIUM
Proprietary Name: AMPICILLIN AND SULBACTAM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A065074
Product Number: 002
Approval Date: Mar 19, 2002
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information